Adaptive Biotechnologies Corp - Common Stock (ADPT)

CUSIP: 00650F109

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class
Equity / Common Stock
Shares outstanding
151,803,139
Total 13F shares
131,007,037
Share change
-4,132,567
Total reported value
$931,519,109
Put/Call ratio
59%
Price per share
$7.12
Number of holders
205
Value change
-$31,344,186
Number of buys
114
Number of sells
79

Quarterly Holders Quick Answers

What is CUSIP 00650F109?
CUSIP 00650F109 identifies ADPT - Adaptive Biotechnologies Corp - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of Adaptive Biotechnologies Corp - Common Stock (ADPT) as of Q3 2022

As of 30 Sep 2022, Adaptive Biotechnologies Corp - Common Stock (ADPT) was held by 205 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 131,007,037 shares. The largest 10 holders included VIKING GLOBAL INVESTORS LP, VANGUARD GROUP INC, Matrix Capital Management Company, LP, BlackRock Inc., ARK Investment Management LLC, Sumitomo Mitsui Trust Holdings, Inc., Nikko Asset Management Americas, Inc., Blue Water Life Science Advisors, LP, Bellevue Group AG, and STATE STREET CORP. This page lists 205 institutional shareholders reporting positions in this security for the Q3 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.